Toggle navigation
Home
Search
Services
Blog
Contact
About
Task A10: Efficacy Testing of Therapeutics for Hepatitis C
Kmt Hepatech, Inc., Edmonton, AB, Canada
Search grants from Kmt Hepatech, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
University of Medicine & Dentistry of NJ
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
National Infrastructure for Standardized and Portable EHR Phenotyping Algorithms
Home-Delivered Intervention for Depressed, Cognitively Impaired Elders
Characterization of Alzheimer's Mutations in ADAM10.
Therapeutic HBV vaccines with glucosidase inhibitors
Evaluation of Hypoglycemic Disorders in Children
Recently added grants:
Treatment of Justice-Involved Emerging Adults with Substance Use Disorders
Extinction and Recovery in Associative Learning
Molecular mechanisms: Dysregulation of monoamine transporters by HIV-1 Tat and cocaine
Multi-method signature of risk for compulsive substance use: Human translation of the incentive-sensitization model
The Opioid Crisis: The Effects and Unintended Consequences of State Policies on Opioid Analgesic Prescribing
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research and Development Contracts (N01)
Project #
272201000016I-0-27200001-1
Application #
8539576
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2012
Total Cost
$1,292,503
Indirect Cost
Institution
Name
Kmt Hepatech, Inc.
Department
Type
DUNS #
202499542
City
Edmonton
State
AB
Country
Canada
Zip Code
76 2-E1
Related projects
NIH 2012
N01 AI
Task A10: Efficacy Testing of Therapeutics for Hepatitis C
/ Kmt Hepatech, Inc.
$1,292,503
NIH 2011
N01 AI
Task A10: Efficacy Testing of Therapeutics for Hepatitis C
Kneteman, Norman / Kmt Hepatech, Inc.
$1,260,145
NIH 2010
N01 AI
Animal Models of Infectious Diseases
/
$50,000
Comments
Be the first to comment on this grant